Form 4: Bausch + Lomb CEO and Chairman Brent Saunders Significantly Increases Personal Stake

Bausch + Lomb's CEO and Chairman, Brent Saunders, has increased his direct beneficial ownership in the company through an open market purchase of 22,000 common shares and a grant of 22,000 matching restricted share units.

Summary

• Brent L. Saunders, CEO and Chairman of Bausch + Lomb Corporation (BLCO), reported an increase in his beneficial ownership.
• On May 22, 2025, Mr. Saunders purchased 22,000 common shares on the open market at a weighted average price of $11.276 per share, with prices ranging from $11.19 to $11.38.
• Concurrently, he was granted 22,000 matching restricted share units (MRSUs) at a price of $0, pursuant to the issuer's matching share program.
• Following these transactions, Mr. Saunders' direct beneficial ownership of common shares increased to 741,156.
• The MRSUs will vest in equal one-third increments on the first, second, and third anniversaries of the grant date, contingent on his continued service.

Sentiment

Score: 8

Explanation: The document reports a significant insider purchase by the CEO and Chairman, coupled with a matching share grant, which is a strong positive signal of management confidence and alignment with shareholder interests. No negative information is present.

Positives

• CEO and Chairman Brent Saunders increased his direct beneficial ownership in Bausch + Lomb, signaling strong confidence in the company's future prospects.
• The open market purchase of 22,000 common shares at market price demonstrates a significant personal investment by top management.
• The grant of 22,000 matching restricted share units aligns management's long-term interests with shareholder value through a vesting schedule tied to continued service.

Risks

• The vesting of the matching restricted share units is subject to the reporting person's continued service, meaning the shares could be forfeited if service ceases under certain conditions.

Future Outlook

The vesting schedule for the matching restricted share units indicates a future commitment, with one-third of the units vesting on each of the first, second, and third anniversaries of the grant date, contingent on continued service.

Management Comments

• "Represents matching restricted share units ('MRSUs') granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program."
• "One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances)."

Industry Context

This filing reflects an insider transaction, specifically an open market purchase and a compensatory grant, which is a common practice for executives to increase their stake and align with shareholder interests. It does not directly provide broader industry trends but indicates management's confidence in Bausch + Lomb within its sector.

Comparison to Industry Standards

• Insider purchases, especially by a CEO and Chairman, are generally viewed positively as they signal management's belief in the company's valuation and future prospects, a common indicator across industries.
• Matching share programs are a standard executive compensation practice designed to incentivize long-term performance and retention, aligning executive interests with those of shareholders, consistent with practices in the healthcare and pharmaceutical sectors.

Corporate Governance

Stakeholder Impact

• Shareholders: The CEO's increased ownership and long-term incentive structure may instill greater confidence in the company's future performance and strategic direction.
• Employees: The matching share program, as evidenced by the MRSU grant, indicates a structured approach to executive incentives, which can indirectly influence broader employee motivation and retention strategies.

Next Steps

• Vesting of matching restricted share units on the first, second, and third anniversaries of the grant date (May 22, 2026, May 22, 2027, and May 22, 2028, respectively), subject to continued service.

Key Dates

Recommendation

Keywords

Bausch + Lomb, BLCO, Brent Saunders, SEC Form 4, Insider Trading, Share Purchase, Restricted Share Units, Executive Compensation, Corporate Governance, Beneficial Ownership